US team finds Parkinson's risk factor
This article was originally published in Clinica
In what could pave the way to a screening test for Parkinson's disease, US researchers have identified a biomarker for the disorder. The researchers found that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinsonian symptoms in mice. The research could lead to earlier diagnosis and hence treatment of the condition, which could help slow disease progression, claimed the researchers, based at the Buck Institute for Age Research, in Novato, California. The findings are published in the February 20 issue of online Journal PLoS One.
You may also be interested in...
Companies continue to throw their hats into the ring against the virus, with strategies ranging from ‘off the shelf’ molecules to novel vaccine and anti-viral therapies
Switzerland’s current economic and trading relationship with the UK is based on its MRA with the EU. So, where does this leave the two countries in trading with one another now each of their relationships with the EU are under threat?
The UK firm speaks about its efforts to tackle the virus as a recent spike in COVID-19 cases outside China heighten concerns.